Latest News & Features
Europe
Court cites lack of inventiveness and failure to meet reproducibility standards | Decision part of broader international litigation with mixed rulings | Generics still barred from selling products until early February. 28 January 2025
Careers
Firm adds partner to Houston office with expertise in biotechnology and complex patent litigation. 28 January 2025
Careers
New recruit brings expertise in developing and prosecuting complex patent portfolios for small molecule drug products | Partner joins from New York law firm Fenwick & West. 24 January 2025
Americas
Teva insisted panel’s narrow interpretation of ‘claims the drug’ will have a seismic effect on the Orange Book | Stay granted while en banc rehearing is under question | Decision could reshape patent listing standards and impact the availability of generic drugs. 23 January 2025
Americas
Will this year be defined by a concerted shift towards ‘One Health’? Simon Kiddle and Rebecca Tollervey of Mewburn Ellis explore. 23 January 2025
Careers
‘Distinguished’ litigator Coke Morgan Stewart takes her place as deputy and interim director of the US Patent and Trademark Office, where she was formerly employed for a decade. 23 January 2025
Europe
In an exclusive interview, the One IPO Search project lead explains how a change in mindset at the office helped ‘unlock the value’ of UK patent data. 23 January 2025
Americas
New president says repeal is first of “many steps the US federal government will take to repair our institutions and our economy” | Defunct order aimed to lower drug costs and place caps on essential medications | Big Pharma argues higher drug prices are necessary to fund R&D for new therapies. 21 January 2025
Unified Patent Court
UK trade association weighs in on Microsoft UPC appeal which deals with issue of representation | Former CIPA head says court should not “divide” European patent profession | SMEs could be forced to opt out patents due to counsel costs. 21 January 2025
Big Pharma
A district court of appeal has paused MSN Pharmaceuticals’ launch | Result comes days after the Federal Circuit restored Novartis’ patent and overturned a decision in favour of MSN | Request is one in a flurry of filings between the pair over the heart-failure drug. 16 January 2025